Production (Stage)
Passage Bio, Inc.
PASG
$0.4228
-$0.0272-6.04%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 29.14% | -35.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.14% | -10.29% | |||
| Operating Income | 3.14% | 10.29% | |||
| Income Before Tax | -21.06% | 34.20% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -21.06% | 34.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -21.06% | 34.20% | |||
| EBIT | 3.14% | 10.29% | |||
| EBITDA | -0.52% | 10.54% | |||
| EPS Basic | -20.56% | 34.30% | |||
| Normalized Basic EPS | 0.08% | 12.64% | |||
| EPS Diluted | -20.56% | 34.30% | |||
| Normalized Diluted EPS | 0.08% | 12.64% | |||
| Average Basic Shares Outstanding | 0.41% | 0.15% | |||
| Average Diluted Shares Outstanding | 0.41% | 0.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||